The spike-ACE2 binding assay: An in vitro platform for evaluating vaccination efficacy and for screening SARS-CoV-2 inhibitors and neutralizing antibodies

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has become a worldwide pandemic, and there is a pressing need for the rapid development of novel therapeutic strategies. SARS-CoV-2 viral entry is mediated by interaction between t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shuangzhe, Gao, Chunhui, Das, Tuhin, Luo, Shuhong, Tang, Hao, Yao, Xinyi, Cho, Chih Yun, Lv, Jingqiao, Maravillas, Kino, Jones, Valerie, Chen, Xiaofeng, Huang, Ruopan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863957/
https://www.ncbi.nlm.nih.gov/pubmed/35218866
http://dx.doi.org/10.1016/j.jim.2022.113244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863957/
https://www.ncbi.nlm.nih.gov/pubmed/35218866
http://dx.doi.org/10.1016/j.jim.2022.113244

Ejemplares similares